Patent · US Active

Method for the detection, preparation and depletion of CD4+ t lymphocytes

US11226332B2 · kind B2 · utility

2Cited by
24References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 10, 2019
Grant dateJan 18, 2022
Priority date
Expiry dateDec 1, 2039

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2469/10
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates an in vitro method for detecting class II restricted CD4+ T cells in a sample. Herein a sample is contacted with an isolated complex of an MHC class II molecule and a peptide. This peptide comprises an MHC class II restricted T cell epitope of an antigenic protein and immediately adjacent thereof, or separated by a linker of at most 7 amino acids a sequence with a [CST]-xx-C or C-xx-[CST] motif. CD4+ T cells are detected by measuring the binding of the complex with cells in the sample, wherein the binding of the complex to a cell is indicative for the presence of CD4+ T cells in the sample. The present invention further relates to an isolated complex of an MHC Class II molecule and a peptide comprising an MHC class II restricted T cell epitope of an antigenic protein and immediately adjacent thereof, or separated by a linker of at most 7 amino acids a sequence with a [CST]-xx-C or C-xx-[CST] motif.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.